Accès gratuit
Biologie Aujourd'hui
Volume 207, Numéro 4, 2013
Page(s) 241 - 247
Publié en ligne 5 mars 2014
  • Berger J., Hinglais N., Intercapillary deposits of IgA-IgG. J Urol Nephrol (Paris), 1968, 74, 694–695. [PubMed] [Google Scholar]
  • Berger J., Yaneva H., Nabarra B., Barbanel C., Recurrence of mesangial deposition of IgA after renal transplantation. Kidney Int, 1975, 7, 232–241. [CrossRef] [PubMed] [Google Scholar]
  • Berthelot L., Papista C., Maciel T.T., Biarnes-Pelicot M., Tissandie E., Wang P.H., Tamouza H., Jamin A., Bex-Coudrat J., Gestin A., Boumediene A., Arcos-Fajardo M., England P., Pillebout E., Walker F., Daugas E., Vrtosvnik F., Flamant M., Benhamou M., Cogné M., Moura I.C., Monteiro R.C.,Transglutaminase is essential for IgA nephropathy development acting through IgA receptors. J Exp Med, 2012, 209, 793–806. [CrossRef] [PubMed] [Google Scholar]
  • Galla J.H., IgA nephropathy. Kidney Int, 1995, 47, 377–387. [CrossRef] [PubMed] [Google Scholar]
  • Gharavi A.G., Moldoveanu Z., Wyatt R.J., Barker C.V., Woodford S.Y., Lifton R.P., Mestecky J., Novak J., Julian B.A., Aberrant IgA1 glycosylation is inherited in familial and sporadic IgA nephropathy. J Am Soc Nephrol, 2008, 19, 1008–1014. [CrossRef] [PubMed] [Google Scholar]
  • Gonzalez-Cabrero J., Egido J., Mampaso F., Rivas M.C., Hernando L., Characterization of circulating idiotypes containing immune complexes and their presence in the glomerular mesangium in patients with IgA nephropathy. Clin Exp Immunol, 1989, 76, 204–209. [PubMed] [Google Scholar]
  • Greer M.R., Barratt J., Harper S.J., Allen A.C., Feehally J., The nucleotide sequence of the IgA1 hinge region in IgA nephropathy. Nephrol Dial Transplant, 1998, 13, 1980–1983. [CrossRef] [PubMed] [Google Scholar]
  • Grossetête B., Launay P., Lehuen A., Jungers P., Bach J.F., Monteiro R.C., Down-regulation of Fc alpha receptors on blood cells of IgA nephropathy patients: evidence for a negative regulatory role of serum IgA. Kidney Int, 1998, 53, 1321–1335. [CrossRef] [PubMed] [Google Scholar]
  • Haddad E., Moura I.C., Macher M.A., Baudouin V., Alberti C., Loirat C., Monteiro R.C., Peuchmaur M., Enhanced expression of the CD71 mesangial IgA1 receptor in Berger disease and Henoch-Schonlein nephritis: association between CD71 expression and IgA deposits. J Am Soc Nephrol, 2003, 14, 327–337. [CrossRef] [PubMed] [Google Scholar]
  • Ikee R., Kobayashi S., Hemmi N., Saigusa T., Namikoshi T., Yamada M., Imakiire T., Kikuchi Y., Suzuki S., Miura S., Involvement of transglutaminase-2 in pathological changes in renal disease. Nephron Clin Pract, 2007, 105, 139–146. [CrossRef] [Google Scholar]
  • Kanamaru Y., Arcos-Fajardo M., Moura I.C., Tsuge T., Cohen H., Essig M., Vrtovsnik F., Loirat C., Peuchmaur M., Beaudoin L., Launay P., Lehuen A., Blank U., Monteiro R.C., Fc alpha receptor I activation induces leukocyte recruitment and promotes aggravation of glomerulonephritis through the FcR gamma adaptor. Eur J Immunol, 2007, 37, 1116–1128. [CrossRef] [PubMed] [Google Scholar]
  • Kokubo T., Hiki Y., Iwase H., Tanaka A., Toma K., Hotta K., Kobayashi Y., Protective role of IgA1 glycans against IgA1 self-aggregation and adhesion to extracellular matrix proteins. J Am Soc Nephrol, 1998, 9, 2048–2054. [PubMed] [Google Scholar]
  • Launay P., Grossetête B., Arcos-Fajardo M., Gaudin E., Torres S.P., Beaudoin L., Patey-Mariaud de Serre N., Lehuen A., Monteiro R.C., Fc alpha receptor (CD89) mediates the development of immunoglobulin A (IgA) nephropathy (Berger’s disease). Evidence for pathogenic soluble receptor-Iga complexes in patients and CD89 transgenic mice. J Exp Med, 2000, 191, 1999–2009. [CrossRef] [PubMed] [Google Scholar]
  • Lorand L., Graham R.M., Transglutaminases: crosslinking enzymes with pleiotropic functions. Nat Rev Mol Cell Biol, 2003, 4, 140–156. [CrossRef] [PubMed] [Google Scholar]
  • Meadow S.R., Scott D.G., Berger disease: Henoch-Schonlein syndrome without the rash. J Pediatr, 1985, 106, 27–32. [CrossRef] [PubMed] [Google Scholar]
  • Monteiro R.C., New insights in the pathogenesis of IgA nephropathy. Nefrologia, 2005, 25, 82–86. [Google Scholar]
  • Monteiro R.C., Van De Winkel J.G., IgA Fc receptors. Annu Rev Immunol, 2003, 21, 177–204. [CrossRef] [PubMed] [Google Scholar]
  • Monteiro R.C., Halbwachs-Mecarelli L., Roque-Barreira M.C., Noël L.H., Berger J., Lesavre P., Charge and size of mesangial IgA in IgA nephropathy. Kidney Int, 1985, 28, 666–671. [CrossRef] [PubMed] [Google Scholar]
  • Monteiro R.C., Moura I.C., Launay P., Tsuge T., Haddad E., Benhamou M., Cooper M.D., Arcos-Fajardo M., Pathogenic significance of IgA receptor interactions in IgA nephropathy. Trends Mol Med, 2002, 8, 464–468. [CrossRef] [PubMed] [Google Scholar]
  • Monteiro R.C., Leroy V., Moura I.C., Arcos-Fajardo M., Benhamou M., Haddad E., Pathogenesis of Berger’s disease: recent advances on the involvement of immunoglobulin A and their receptors. Med Sci (Paris), 2003, 19, 1233–1241. [CrossRef] [EDP Sciences] [PubMed] [Google Scholar]
  • Moura I.C., Centelles M.N., Arcos-Fajardo M., Malheiros D.M., Collawn J.F., Cooper M.D., Monteiro R.C., Identification of the transferrin receptor as a novel immunoglobulin (Ig)A1 receptor and its enhanced expression on mesangial cells in IgA nephropathy. J Exp Med, 2001, 194, 417–425. [CrossRef] [PubMed] [Google Scholar]
  • Moura I.C., Arcos-Fajardo M., Sadaka C., Leroy V., Benhamou M., Novak J., Vrtovsnik F., Haddad E., Chintalacharuvu K.R., Monteiro R.C., Glycosylation and size of IgA1 are essential for interaction with mesangial transferrin receptor in IgA nephropathy. J Am Soc Nephrol, 2004, 15, 622–634. [CrossRef] [PubMed] [Google Scholar]
  • Moura I.C., Arcos-Fajardo M., Gdoura A., Leroy V., Sadaka C., Mahlaoui N., Lepelletier Y., Vrtovsnik F., Haddad E., Benhamou M., Monteiro R.C., Engagement of transferrin receptor by polymeric IgA1: evidence for a positive feedback loop involving increased receptor expression and mesangial cell proliferation in IgA nephropathy. J Am Soc Nephrol, 2005, 16, 2667–2676. [CrossRef] [PubMed] [Google Scholar]
  • Muso E., Yoshida H., Takeuchi E., Yashiro M., Matsushima H., Oyama A., Suyama K., Kawamura T., Kamata T., Miyawaki S., Izui S., Sasayama S., Enhanced production of glomerular extracellular matrix in a new mouse strain of high serum IgA ddY mice. Kidney Int, 1996, 50, 1946–1957. [CrossRef] [PubMed] [Google Scholar]
  • Novak J., Julian B.A., Tomana M., Mestecky J., IgA glycosylation and IgA immune complexes in the pathogenesis of IgA nephropathy. Semin Nephrol, 2008, 28, 78–87. [CrossRef] [PubMed] [Google Scholar]
  • Oh H.J., Ahn S.V., Yoo D.E., Kim S.J., Shin D.H., Lee M.J., Kim H.R., Park J.T., Yoo T.H., Kang S.W., Choi K.H., Han S.H., Clinical outcomes, when matched at presentation, do not vary between adult-onset Henoch-Schonlein purpura nephritis and IgA nephropathy. Kidney Int, 2012, 82, 1304–1312. [CrossRef] [PubMed] [Google Scholar]
  • Rifai A., Small P.A. Jr., Teague PO, Ayoub EM., Experimental IgA nephropathy. J Exp Med, 1979, 150, 1161–1173. [CrossRef] [PubMed] [Google Scholar]
  • Sano T., Hiki Y., Kokubo T., Iwase H., Shigematsu H., Kobayashi Y., Enzymatically deglycosylated human IgA1 molecules accumulate and induce inflammatory cell reaction in rat glomeruli. Nephrol Dial Transplant, 2002, 17, 50–56. [CrossRef] [Google Scholar]
  • Shweke N., Boulos N., Jouanneau C., Vandermeersch S., Melino G., Dussaule J.C., Chatziantoniou C., Ronco P., Boffa J.J., Tissue transglutaminase contributes to interstitial renal fibrosis by favoring accumulation of fibrillar collagen through TGF-beta activation and cell infiltration. Am J Pathol, 2008, 173, 631–642. [CrossRef] [PubMed] [Google Scholar]
  • Silva F.G., Chander P., Pirani C.L., Hardy M.A., Disappearance of glomerular mesangial IgA deposits after renal allograft transplantation. Transplantation, 1982, 33, 241–246. [PubMed] [Google Scholar]
  • Simon P., Ramée M.P., Autuly V., Laruelle E., Charasse C., Cam G., Ang K.S., Epidemiology of primary glomerular diseases in a French region. Variations according to period and age. Kidney Int, 1994, 46, 1192–1198. [CrossRef] [PubMed] [Google Scholar]
  • Suzuki H., Fan R., Zhang Z., Brown R., Hall S., Julian B.A., Chatham W.W., Suzuki Y., Wyatt R.J., Moldoveanu Z., Lee J.Y., Robinson J., Tomana M., Tomino Y., Mestecky J., Novak J., Aberrantly glycosylated IgA1 in IgA nephropathy patients is recognized by IgG antibodies with restricted heterogeneity. J Clin Invest, 2009, 119, 1668–1677. [PubMed] [Google Scholar]
  • Tanaka M., Seki G., Someya T., Nagata M., Fujita T., Aberrantly glycosylated IgA1 as a factor in the pathogenesis of IgA nephropathy. Clin Dev Immunol, 2011, 2011, 470803. [CrossRef] [PubMed] [Google Scholar]
  • Tomana M., Novak J., Julian B.A., Matousovic K., Konecny K., Mestecky J., Circulating immune complexes in IgA nephropathy consist of IgA1 with galactose-deficient hinge region and antiglycan antibodies. J Clin Invest, 1999, 104, 73–81. [CrossRef] [PubMed] [Google Scholar]
  • Valentijn R.M., Radl J., Haaijman J.J., Vermeer B.J., Weening J.J., Kauffmann R.H., Daha M.R., van Es L.A., Circulating and mesangial secretory component-binding IgA-1 in primary IgA nephropathy. Kidney Int, 1984, 26, 760–766. [CrossRef] [PubMed] [Google Scholar]
  • van den Wall Bake A.W., Bruijn J.A., Accavitti M.A., Crowley-Nowick P.A., Schrohenloher R.E., Julian B.A., Jackson S., Kubagawa H., Cooper M.D., Daha M.R., Mestecky J., Shared idiotypes in mesangial deposits in IgA nephropathy are not disease-specific. Kidney Int, 1993, 44, 65–74. [CrossRef] [PubMed] [Google Scholar]
  • Zheng F., Kundu G.C., Zhang Z., Ward J., DeMayo F., Mukherjee A.B., Uteroglobin is essential in preventing immunoglobulin A nephropathy in mice. Nat Med, 1999, 5, 1018–1025. [CrossRef] [PubMed] [Google Scholar]

Les statistiques affichées correspondent au cumul d'une part des vues des résumés de l'article et d'autre part des vues et téléchargements de l'article plein-texte (PDF, Full-HTML, ePub... selon les formats disponibles) sur la platefome Vision4Press.

Les statistiques sont disponibles avec un délai de 48 à 96 heures et sont mises à jour quotidiennement en semaine.

Le chargement des statistiques peut être long.